The number of individuals in the U.S. living with diabetes continues to rise ([@B1]), and these patients have an increased risk of cardiovascular complications and premature mortality ([@B2]). Obesity is associated with the development of type 2 diabetes ([@B3],[@B4]); however, the relationship between the most common measure of obesity, the BMI, and mortality among patients with diabetes is less clear. To date, studies have reported positive associations ([@B5]), negative associations ([@B6]--[@B9]), U-shaped associations ([@B10],[@B11]), or no association ([@B12]) between BMI and mortality among patients with diabetes. However, the BMI has some limitations as an indicator of obesity ([@B13]), and no study has been reported on the relationship with other indicators of adiposity. Thus, the purpose of this prospective cohort study was to determine the associations of waist circumference (WC) and BMI with all-cause mortality.

RESEARCH DESIGN AND METHODS {#s1}
===========================

Sample {#s2}
------

The sample included 847 white and 553 African American diabetic adults (18--69 years of age) from the Pennington Center Longitudinal Study (PCLS), which is an investigation of the effects of obesity and lifestyle factors on the development of chronic diseases and premature mortality. The sample is composed of volunteers who participated in studies conducted at the Pennington Biomedical Research Center (PBRC) in Baton Rouge, Louisiana, between 1994 and 2009 ([@B14],[@B15]). Each participant was seen once at baseline, and mortality outcomes were assessed by linkage with the National Death Index. Written informed consent was provided, and all procedures were approved by the PBRC Institutional Review Board.

Baseline exposures {#s3}
------------------

Diabetes status was determined using a combination of self-reported physician diagnosis, fasting blood glucose (≥126 mg/dL), and diabetic medications. Height and weight were measured after outer clothing, heavy pocket items, and shoes were removed, and BMI was calculated (weight \[kg\]/height \[m^2^\]). WC was measured at the midpoint between the inferior border of the ribcage and the superior aspect of the iliac crest.

Covariates {#s4}
----------

Age was computed from birth and observation dates, and year of examination was included as a covariate to account for potential temporal trends in baseline measurements. Smoking status, alcohol consumption, and leisure-time physical activity were self-reported by questionnaire.

Ascertainment of mortality status {#s5}
---------------------------------

The vital status of all participants was determined by linkage to the National Death Index ([@B16]). The primary end point for this analysis was deaths from all causes that occurred between 6 months after the baseline assessment and 31 December 2009. The average length of follow-up was 6.7 years (SD 3.6; maximum 15.8).

Statistical analysis {#s6}
--------------------

Cox proportional hazards regression was used to assess the associations of WC and BMI with all-cause mortality, adjusting for age, sex, race, baseline examination year, smoking status, alcohol consumption, and physical activity. Model 1 included age, sex and baseline examination year as covariates, and model 2 additionally included race (white, African American) smoking status (never, former, current, unknown), alcohol consumption (no, yes, unknown), and leisure-time physical activity (\<4 h/week, ≥4 h/week, unknown). Hazard ratios (HRs) are expressed per SD of each independent variable (WC = 15 cm; BMI = 7 kg/m^2^). The presence of interactions was tested by including race, sex, WC, and BMI interaction terms in the models. To compare dose-response associations, HRs were calculated across tertiles of WC and BMI.

RESULTS {#s7}
=======

A total of 86 deaths (33 from cardiovascular disease, 23 from cancer, and 30 from other causes) occurred during 9,316 person-years of follow-up. At baseline, decedents were significantly older (57.0 \[SD 7.5\] vs. 53.3 \[9.5\] years), had a higher mean WC (115.4 \[16.0\] vs. 110.2 \[15.1\] cm) than survivors, and a lower percentage were women (48.8 vs. 66.7%; [Supplementary Table](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0219/-/DC1)). Mean BMI did not differ between decedents and survivors (36.3 \[7.1\] vs. 35.4 \[6.6\] kg/m^2^) nor did the percentage of African Americans (39.5 vs. 39.5%).

In models adjusted for age, sex, and examination year, WC (HR 1.41 \[95% CI 1.15--1.73\]) and BMI (1.32 \[1.07--1.64\]) were significantly associated with mortality. In multivariable-adjusted models, WC (1.40 \[1.14--1.72\]) and BMI (1.29 \[1.04--1.61\]) remained significant predictors. Higher death rates were observed in men (1.78 \[1.12--2.81\]) and African Americans (1.69 \[1.08--2.66\]) after adjustment for WC. Higher death rates were similarly observed after adjustment for BMI. However, no significant race or sex interactions were observed.

The results of the categorical analyses are presented in [Fig. 1](#F1){ref-type="fig"}. There were significant linear trends for mortality across tertiles of both WC and BMI. In both cases, participants in tertile 3 had a significantly elevated risk of mortality compared with tertile 1.

![HRs for all-cause mortality across tertiles of BMI (*A*) and WC (*B*) are shown among patients with diabetes in the Pennington Center Longitudinal Study. Error bars represent the 95% CI. Cutoffs for the tertiles were 32 and 38 kg/m^2^ for BMI and 104 and 116 cm for WC. HRs are adjusted for age, year of examination, sex, race, smoking, alcohol consumption, and physical activity.](3128fig1){#F1}

CONCLUSIONS {#s8}
===========

The results of this study indicate a significant, positive association between BMI and mortality rates in this biracial sample of patients with diabetes. This is in contrast to some previous studies that have documented inverse ([@B6]--[@B9]) or U-shaped associations ([@B10],[@B11]). However, our results are similar to those from Finnish patients with diabetes, where the HRs across successive tertiles of BMI were 1.00 (reference), 0.94 (95% CI 0.80--1.10), and 1.20 (1.02--1.40) ([@B5]). The reasons for different associations across studies are not clear; however, the samples differed at baseline by mean level of BMI, health status, ethnicity, and duration of diabetes.

To our knowledge, the role of obesity in predicting mortality among patients with diabetes has not been explored using measures other than BMI. Our results indicate that decedents had a higher WC but not a higher BMI than survivors at baseline. Further, the association between WC and mortality was similar to that with BMI.

This study has several strengths and weaknesses. The reliance on direct assessments of WC and BMI and the linkage to the National Death Index are marked strengths. However, the relatively small, nonrepresentative sample and the lack of information on duration of diabetes and comorbidities are limitations. The sample size was not sufficient to allow for cause-specific analyses.

In conclusion, the results of this study indicate that maintaining a healthy WC and BMI are important for individuals living with diabetes. The association with WC was similar to that of BMI.

This article contains Supplementary Data online at <http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc13-0219/-/DC1>.
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